Two-stage CD8+ CAR T-cell differentiation in patients with large B-cell lymphoma

Related articles

1. Low-dose CD7 chimeric antigen receptor T cells for relapsed/refractory T-cell lymphomas: single-arm, open-label, phase I study

   This article has 13 authors:

   1. Kai Hu
   2. Fan Yang
   3. Rui Liu
   4. Zhonghua Fu
   5. Yuelu Guo
   6. Lixia Ma
   7. Miaomiao Cao
   8. Biping Deng
   9. Alex H. Chang
   10. Haifeng Wu
   11. Shilin Gan
   12. Chen Chen
   13. Xiaoyan Ke

2. Long-term follow-up results of anti-BCMA CAR-T cell therapy combined with autologous hematopoietic stem cell transplantation in relapsed/refractory multiple myeloma with extramedullary disease

   This article has 10 authors:

   1. Xin Li
   2. Can Liu
   3. Siyan Niu
   4. Ru Li
   5. Shuquan Gao
   6. Rui Cui
   7. Jia Wang
   8. Yao Qi
   9. Jingyi Li
   10. Qi Deng

3. PD-1 regulates CD4+ T cell-mediated CD8+ T cell responses in the brain to balance viral control and neuroinflammation

   This article has 15 authors:

   1. Aron Lukacher
   2. Arrienne Butic
   3. Elia Afanasiev
   4. Samantha Spencer
   5. Mofida Abdelmageed
   6. Anirban Paul
   7. Kalynn Alexander
   8. Katelyn Ayers
   9. Todd Schell
   10. Matthew Lauver
   11. Ge Jin
   12. Samantha Borys
   13. Laurent Brossay
   14. Jo Anne Stratton
   15. Vonn Walter